US Broker Ratings

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA), a biopharmaceutical innovator in the healthcare sector, is attracting attention with its robust focus on RNA therapeutics through its groundbreaking Antibody Oligonucleotide Conjugates (AOCs) platform...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Robust 131.88% Upside Potential Beckons Investors

Telix Pharmaceuticals Limited (TLX) is making significant waves in the biotechnology industry, particularly in the realm of radiopharmaceuticals. As a commercial-stage biopharmaceutical company, Telix is dedicated to the development and..

HealthEquity, Inc. (HQY) Stock Analysis: Analyst Consensus Reveals 18% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands out as a compelling investment opportunity within the healthcare sector, specifically in the health information services industry. With a significant market capitalization of $8.81 billion,..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 49% Potential Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a healthcare stalwart based in Barcelona, Spain, offers an intriguing opportunity for investors looking to tap into the drug manufacturing industry. With a market capitalization of $6.93..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 151.69% Potential Upside

Investors searching for high-potential opportunities in the biotech sector should cast an eye toward Soleno Therapeutics, Inc. (NASDAQ: SLNO). With a market capitalization of $2.42 billion, this clinical-stage biopharmaceutical company,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a titan in the diagnostics and research industry, is making waves with its innovative cancer screening and diagnostic products. With a market capitalization of $19.15..

Glaukos Corporation (GKOS) Stock Analysis: Unveiling a 20.96% Potential Upside Amidst Rapid Revenue Growth

Glaukos Corporation (NYSE: GKOS) stands as a vanguard in the healthcare sector, specifically within the medical devices industry. Based in the United States, this ophthalmic pharmaceutical and medical technology company..

iRhythm Technologies, Inc. (IRTC) Investor Outlook: A Strong Buy with 23.68% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) is gaining significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $5.73 billion, this San Francisco-based company..

Legend Biotech Corporation (LEGN): Analyst Consensus Signals a Potential 165% Upside

Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling proposition for investors keen on the biotech sector, particularly in the realm of innovative cancer therapies. With a market capitalization of $5.2..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 14.97% Upside in Healthcare

BrightSpring Health Services, Inc. (BTSG), a key player in the healthcare sector, has been capturing investor attention with its robust growth prospects and strategic positioning in the health information services..

Elanco Animal Health (ELAN): Investor Outlook with an 8.24% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) presents a compelling investment narrative within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic animal health products. With..

Guardant Health, Inc. (GH) Stock Analysis: A Look at the 38.5% Revenue Growth and Investor Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology sector, has captured the attention of investors with its impressive 38.5% revenue growth. Based in Palo Alto, California, the..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 35.91% Upside in the Health Information Services Sector

Doximity, Inc. (NYSE: DOCS) has positioned itself as a major player within the healthcare sector, specifically in health information services, by providing a digital platform designed for medical professionals. With..

Akero Therapeutics (AKRO) Stock Analysis: A Look at Its Growth Potential and Market Position

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing the attention of biotech investors with its promising pipeline and strategic focus on metabolic diseases. Headquartered in South San Francisco, California, Akero is..

West Pharmaceutical Services, Inc. (WST): Unlocking a 29.4% Upside with Strong Growth Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a stalwart in the healthcare sector, is capturing attention with its robust potential upside of 29.4%, positioning itself as a compelling target for investors..

Option Care Health, Inc. (OPCH) Investor Outlook: Decoding a 19.38% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) is drawing attention in the healthcare sector, particularly for its distinct position within the medical care facilities industry. With a market capitalization of $4.8..

Krystal Biotech, Inc. (KRYS): Investor Outlook with a Strong Buy Consensus and 5.18% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its innovative approach to addressing high unmet medical needs...

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with a 28.65% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing considerable investor attention with its promising upside potential of 28.65%. As a key entity in the..

Bruker Corporation (BRKR) Stock Analysis: A Look at Analyst Ratings and Growth Potential

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a unique investment opportunity for those intrigued by its scientific instrumentation and diagnostic solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: Unveiling a 58% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising growth trajectory and a notable potential upside of 58.61%. Specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds